Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-jRCTs041180172
JPRN-jRCTs041180172CompletedPhase 2

Clinical study about the intraocular tissue plasminogen activator(t-PA) injection. - Clinical study about the intraocular tissue plasminogen activator(t-PA

Horiguchi Masayuki0 sites56 target enrollmentStarted: March 29, 2019Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Trial Snapshot

Phase
Phase 2
Status
Completed
Sponsor
Enrollment
56
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

For diabetic retinopathy, retinal vein occlusion, and macular edema due to macular degeneration Corrected visual acuity, which is an evaluation of visual acuity, showed a significant improvement in corrected visual acuity before and 12 months after surgery. However, the foveal retinal thickness, which was anatomically evaluated, showed a decrease between preoperative and 12 months after surgery, but no significant difference was observed.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20age to ot applicable (—)
Sex
All

Inclusion Criteria

  • •The patient who was enough explained and understand this study.
  • •The patient who agree this study by the free will and sign consent forms.
  • •The patient who was diagnosed adjuvant is appropriate.

Exclusion Criteria

  • •The patient who judged adjuvant is inappropriate by principal investigator or member of a research project.

Investigators

Sponsor
Horiguchi Masayuki

Similar Trials

Unknown
Not Applicable
Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.Macular Edema
NCT04601675He Eye Hospital100
Unknown
Not Applicable
Comparison Between Treatment With Yellow Micropulse Laser and Green Conventional Laser in Diabetic Macular EdemaDiabetic Macular Edema
NCT01928654Luigi Sacco University Hospital32
Completed
Phase 3
Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection for Diabetic Macular EdemaDiabetic Macular EdemaDiabetes
NCT00764244Assistance Publique - Hôpitaux de Paris72
Completed
Phase 3
Bevacizumab Versus Ranibizumab for Diabetic RetinopathyDiabetic Macular EdemaProliferative Diabetic RetinopathyDiabetic Retinopathy
NCT00545870Ursula Schmidt-Erfurth, M.D.30
Completed
Not Applicable
A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)Diabetic Retinopathy
NCT04477707Bayer206